User login
Language
Anonymous's groups in this site
User is not a member of any group.
Your groups across all your sites
User is not a member of any group.
Recent Content
Recent Comments
- WHO convening meeting to discuss Mpox status in Africa 1 week 2 hours ago
- Writing is on the wall for the US at COP29 --BBC 1 week 1 day ago
- Update: Biden announced vaccine doses and cash for Africa 1 month 3 weeks ago
- WHO's authorization of mpox vaccine should ease global access 2 months 4 days ago
Who's online
There are currently 0 users online.
You are here
REUTERS Dec. 9, 2014
CHICAGO -- The U.S. Department of Health and Human Services on Tuesday offered liability protections to drugmakers rushing to develop Ebola vaccines and urged other countries to follow suit.
Health and Human Services (HHS) Secretary Sylvia Burwell made the announcement as part of the Public Readiness and Emergency Preparedness (PREP) Act in a move aimed at encouraging the development and availability of experimental Ebola vaccines.
The declaration provides immunity under U.S. law against legal claims related to the manufacturing, testing, development, distribution, and administration of three vaccines for the Ebola virus. However, it does not provide immunity for a claim brought in a court outside the United States...
Read full story
http://www.reuters.com/article/2014/12/09/us-health-ebola-vaccine-idUSKBN0JN1S920141209
Comments
How Ebola Drug Trials Today Could Shape Future Drug Development
XCONOMY by Frank Vinlua Dec. 9, 2014
Ebola research has yet to yield a proven vaccine or antiviral drug but the work done so far could be paving the way for something else—faster and more efficient ways of testing drug candidates for other diseases.
Jeffrey Spaeder, chief medical officer for Durham, NC, contract research organization Quintiles (NYSE: Q), says the current Ebola outbreak has placed urgency on a drug development process that typically requires years of testing to determine safety and efficacy. But he says urgency also leads life science companies, non-profit organizations, and government bodies to work together in new ways.
http://www.xconomy.com/raleigh-durham/2014/12/09/how-ebola-drug-trials-today-could-shape-future-drug-development/